passages.id: 60
passages.type: sentence
passages.text: Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo .
entities.id: 61
entities.type: intervention
entities.text: methotrexate
entities.id: 62
entities.type: intervention
entities.text: placebo
entities.id: 63
entities.type: outcome
entities.text: weakness progression
entities.id: 64
entities.type: participant
entities.text: inclusion body myositis